Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes

NCT04916470 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

617

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2

Interventions

DRUG: Semaglutide
DRUG: Placebo (Semaglutide)

Sponsor

Novo Nordisk A/S